NLARx Newsletter Header
NLARx News
October 12, 2010
In This Issue
NLARx News
In the States
Outrage of the Week
Advertising & Marketing
Pharma Watch
PBM Watch
Pricing
Patents & Generics
Trade
Medicare & Medicaid
Safety & Clinical Trials
Conflicts of Interest
NLARx on Facebook
Quick Links
Join Our Mailing List
NLARx  in the News
Drug Makers Continue to Flout "Best Price" Law, and Predictions are Compliance is About to Get Worse more
News from the States
Hawaii: Hawaii AG settles AWP suits for $82M more
Kansas: Mental Health Drugs Are the Costliest for Kansas Taxpayers more
Maine: Drug Disposal Topic of Maine Conference more
Maine to Get $382,521 in Drug Settlement more
Massachusetts: Merck Found Liable For Overcharging Massachusetts more
New Jersey: New Jersey Supreme Court Allows Mass-Marketing Fraud Class Action, Decision Adopts Public Citizen's Analysis more
New York: New Rules for New York's EPIC Senior Citizen Drug Program Will Require Filing Appeals If Medicare Refuses Payment more
Pennsylvania: Pa. AG Secures $27M Award from Bristol-Myers Squibb more
Texas: Texas Seniors Get Drugs From Online Canadian Pharmacies more
Outrage of the Week
Big Pharma Behaving Badly: A Timeline of Settlements more
Advertising and Marketing
Novartis Pays $422M For Off-Label Marketing  more
The Shocking Truth About Free Lunches And Pens more
Europe Scraps 'Advertising In Disguise' Proposal more
Pharma Watch
Pfizer Unit Hid Prempro's Health Risks, Lawyer Says more
Living In Unethical Times: Carl Elliott Explains more
Novartis Whistleblower Speaks: 'We Wasted Money' more
Side Effects May Include Lawsuits more
J&J Asks Judge to Toss Omnicare Kickbacks Case more
Pfizer Unit Hid Prempro's Health Risks, Lawyer Says more
Feds Investigate Whether Drug Companies Paid Bribes Overseas more
PBM Watch
Express Scripts, Other PBMs Go Data-Diving to Predict Health Problems more
Florida Independent Pharmacies Take Action Against CVS-Caremark Anti Trust Practices more
Pharmacists Slam Wal-Mart's New Medicare Drug Plan more
US Senate Aging Panel Probes CVS Caremark Medicare Plans more
Florida Independent Pharmacies Take Action Against CVS-Caremark Anti Trust Practices more
New Bedford to Get $11,000 from CVS for Overcharges more
Drug Prices and Reimbursement 
Supreme Court To Hear Appeal On Overcharges more
Feds To Fine Pharma For Failing To Report Prices more
Controversy Over Colchicine Price Hike Flares more
Biologics Can Achieve Great Success - But At Great Cost more
Many Adults Skip Vaccines Because Of Costs more
Data Firm Sees 2011 Drug Sales Rising 5-7 Percent more
Patents and Generics
Want To Milk A Cash Cow? Try Pediatric Exclusivity more
NIH Joins AIDS Patent Pool; Where Is Pharma? more
Patents Ending, Eli Lilly Chases New Drugs more
Senator Wants Anti-Counterfeit Trade Deal Reviewed more
Trade
Senator Wants Anti-Counterfeit Trade Deal Reviewed more
Police Break Up Indian Protest Over Free Trade Talks more
Medicare and Medicaid
Health Care Reform: Prove it Works and CMS Will Pay more
Bloomberg Analysis Finds 'Doughnut Hole' Deal To Cost Drugmakers Less Than 1% Of Profits more
Drug Makers Accused of Ignoring Price Law more
Merck To Pay Millions Over Mass. Allegations Of Inflated Wholesale Rate more
Recession Drove Many to Medicaid Last Year more
More Seniors in Coverage Gap Likely to Get Help, Study Shows more
More Options for Seniors with High Drug Costs more
New CMS chief to focus on Quality, Organization and Costs more
Safety and Clinical Trials
Are Osteoporosis Drugs Weakening, Rather Than Strengthening Our Bones? more
Worries About Using Plavix With Heartburn Pills May Be Overblown more
FDA: Improving Safety of Global Drug Supply Top Priority more
Novartis Wins Second Trial Over Zometa Risks more
FDA Chief Focuses on Antibiotic Resistance more
A $95 Million Effort to Study Drugs Already Being Prescribed to Kids more
New Drug Disposal Bill Applauded more
Official Says J.&J. Plants Had Widespread Failings more
FDA Bounces A Biologic, But No Trials Required more
FDA Warns Gilead About Manufacturing Problems more
FDA: New Rules To Report Safety Info From Trials more
Conflict of Interest, CME, and Academic Detailing
Pfizer Attacks Journal For Undisclosed Conflicts more
Consumer Groups Shut Out of Comparative Effectiveness Board more
Subscribe to the NLARx Blog and Join us on Facebook!
For up-to-the-minute posting of news of interest and events, become a fan of NLARx on Facebook here and subscribe to our Blog.